All data are based on the daily closing price as of December 26, 2024
h

Huons

243070.KQ
18.77 USD
-0.28
-1.47%

Overview

Last close
18.77 usd
Market cap
221.63M usd
52 week high
35.51 usd
52 week low
15.28 usd
Target price
37.87 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.5628
Price/Book Value
0.961
Enterprise Value
287.10M usd
EV/Revenue
0.7145
EV/EBITDA
5.9576

Key financials

Revenue TTM
390.22M usd
Gross Profit TTM
182.76M usd
EBITDA TTM
50.98M usd
Earnings per Share
N/A usd
Dividend
0.43 usd
Total assets
566.22B usd
Net debt
N/A usd

About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices. The company was formerly known as Kwang Myung Pharm and changed its name to Huons Co., Ltd. in June 2003. Huons Co., Ltd. was founded in 1965 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    243070.KQ
  • Exchange
    KQ
  • Isin
    KR7243070000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://www.huons.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top